The Foundation for Sarcoidosis Research (FSR) brought together more than 40 leading clinicians and researchers from around the world…
Articles by Steve Bryson, PhD
Higher, daily exposure to microorganisms during childhood is significantly associated with an increased chance of developing sarcoidosis in adulthood,…
Atyr Pharma and the U.S. Food and Drug Administration (FDA) have aligned on the specific main outcome analysis of…
A global Phase 3 clinical trial evaluating efzofitimod, Atyr Pharma’s investigational therapy, in people with pulmonary sarcoidosis will…
Damage to and the loss of bile ducts, which are the tubes that carry the digestive fluid bile from the…
A woman in her 50s in Florida who presented with recurrent ministrokes was eventually diagnosed with sarcoidosis only affecting…
A new modeling approach that incorporates standard tests and clinical signs can identify people who have sarcoidosis-associated uveitis (SAU),…
An immunosuppressive medication that’s used to prevent organ rejection after transplantation successfully treated cutaneous sarcoidosis, a type of…
Bone fractures, particularly those of the spine, are a common complication among people with sarcoidosis, according to a study…
Blood levels of the angiotensin-converting enzyme (ACE) — a common sarcoidosis biomarker — were able to distinguish between newly…